Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tom Storskrubb, Pertti Aro, Jukka Ronkainen, Michael Vieth, Manfred Stolte, Karin Wreiber, Lars Engstrand, Henry Nyhlin, Elisabeth Bolling-Sternevald, Nicholas J. Talley & Lars Agréus. (2005) A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: A report on histology and H. pylori detection in the general adult population. Scandinavian Journal of Gastroenterology 40:3, pages 302-311.
Read now
Read now
Articles from other publishers (20)
Elizabeth A. Marcus & David R. Scott. 2023. Helicobacter pylori. Helicobacter pylori
25
37
.
Karam Dawood & Israa Mamdooh. 2021. Esophagitis and Gastritis - Recent Updates. Esophagitis and Gastritis - Recent Updates.
Hashem B. El-Serag, John Y. Kao, Fasiha Kanwal, Mark Gilger, Frank LoVecchio, Steven F. Moss, Sheila Crowe, Adam Elfant, Thomas Haas, Ronald J. Hapke & David Y. Graham. (2018) Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clinical Gastroenterology and Hepatology 16:7, pages 992-1002.e6.
Crossref
Crossref
Elizabeth A. Marcus, George Sachs & David R. Scott. (2016) Eradication of Helicobacter pylori Infection. Current Gastroenterology Reports 18:7.
Crossref
Crossref
Lars Agréus, Nicholas J. Talley & Michael Jones. (2015)
Value of the “Test & Treat” Strategy for Uninvestigated Dyspepsia at Low Prevalence Rates of
Helicobacter pylori
in the Population
. Helicobacter 21:3, pages 186-191.
Crossref
Crossref
Elizabeth A. Marcus & David R. Scott. 2016. Helicobacter pylori. Helicobacter pylori
23
34
.
L. Lundell, M. Vieth, F. Gibson, P. Nagy & P. J. Kahrilas. (2015) Systematic review: the effects of long‐term proton pump inhibitor use on serum gastrin levels and gastric histology. Alimentary Pharmacology & Therapeutics 42:6, pages 649-663.
Crossref
Crossref
R. Fiocca, L. Mastracci, S. E. Attwood, C. Ell, J.‐P. Galmiche, J. Hatlebakk, A. Bärthel, G. Långström, T. Lind & L. Lundell. (2012) Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5‐year follow‐up in the LOTUS trial. Alimentary Pharmacology & Therapeutics 36:10, pages 959-971.
Crossref
Crossref
David Y. Graham & Robert M. Genta. (2008) Long-term proton pump inhibitor use and gastrointestinal cancer. Current Gastroenterology Reports 10:6, pages 543-547.
Crossref
Crossref
David Y. Graham & Francis K.L. Chan. (2008) NSAIDs, Risks, and Gastroprotective Strategies: Current Status and Future. Gastroenterology 134:4, pages 1240-1246.
Crossref
Crossref
James G. Fox & Timothy C. Wang. (2007) Inflammation, atrophy, and gastric cancer. Journal of Clinical Investigation 117:1, pages 60-69.
Crossref
Crossref
Zunwu Zhang. (2008) The Risk of Gastric Cancer in Patients with Duodenal and Gastric Ulcer: Research Progresses and Clinical Implications. Journal of Gastrointestinal Cancer 38:1, pages 38-45.
Crossref
Crossref
Hae Yeon Kang, Nayoung Kim, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Sook Hyang Jeong, Dong Ho Lee, Hyun Chae Jung & In Sung Song. (2006) Progression of Atrophic Gastritis and Intestinal Metaplasia Drives Helicobacter pylori Out of the Gastric Mucosa. Digestive Diseases and Sciences 51:12, pages 2310-2315.
Crossref
Crossref
L. LUNDELL, N. HAVU, P. MIETTINEN, H. E. MYRVOLD, L. WALLIN, R. JULKUNEN, K. LEVANDER, J. G. HATLEBAKK, B. LIEDMAN, M. LAMM, A. MALM & A. WALAN. (2006) Changes of gastric mucosal architecture during long‐term omeprazole therapy: results of a randomized clinical trial. Alimentary Pharmacology & Therapeutics 23:5, pages 639-647.
Crossref
Crossref
Jean-Dominique de Korwin & Muriel Frédéric. (2006) Gastrites chroniques. EMC - Gastro-entérologie 1:1, pages 1-16.
Crossref
Crossref
M. P. Bergman, E. C. Klinkenberg‐Knol, G. Faller, A. van der Aar, W. Lakhai, C. M. J. E. Vandenbroucke‐Grauls, E. J. Kuipers & B. J. Appelmelk. (2005) Long‐term acid suppression by omeprazole in gastro‐oesophageal reflux disease patients does not lead to anti‐gastric autoantibody production. Alimentary Pharmacology & Therapeutics 21:8, pages 977-983.
Crossref
Crossref
Yi Wen, Elizabeth A. Marcus, Uday Matrubutham, Martin A. Gleeson, David R. Scott & George Sachs. (2003)
Acid-Adaptive Genes of
Helicobacter pylori
. Infection and Immunity 71:10, pages 5921-5939.
Crossref
Crossref
Marina Mollenhauer-Rektorschek, Guido Hanauer, George Sachs & Klaus Melchers. (2002) Expression of UreI is required for intragastric transit and colonization of gerbil gastric mucosa by Helicobacter pylori. Research in Microbiology 153:10, pages 659-666.
Crossref
Crossref
Neal S. Goldstein. (2002)
Chronic Inactive Gastritis and Coccoid
Helicobacter pylori
in Patients Treated for Gastroesophageal Reflux Disease or With
H pylori
Eradication Therapy
. American Journal of Clinical Pathology 118:5, pages 719-726.
Crossref
Crossref
Hideo SuzukiAkinori YanakaTakeshi ShibaharaHirofumi MatsuiAkira NakaharaNaomi TanakaHiroshi MutoTakashi Momoi & Yasuo Uchiyama. (2002) Ammonia-induced apoptosis is accelerated at higher pH in gastric surface mucous cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 283:4, pages G986-G995.
Crossref
Crossref